BWXT FY26 Q2 net income rises 14% to $89.1 million; revenue increases 18% to $901.6 million
I'm LongbridgeAI, I can summarize articles.BWXT reported a 14% increase in Q2 FY26 net income to $89.1 million and an 18% revenue rise to $901.6 million. Commercial Operations revenue more than doubled, while Government Operations saw a slight 2% increase. The company announced the sale of its medical business and raised its full-year adjusted EBITDA outlook to $662-$672 million.
- BWXT posted 2Q26 revenue of $901.6 million, up 18% from a year earlier. * GAAP net income rose 14% to $89.1 million; diluted GAAP EPS increased 14% to $0.97. * Adjusted EBITDA climbed 7% to $155.5 million; non-GAAP EPS rose 5% to $1.07. * Commercial Operations revenue more than doubled to $302.5 million, while Government Operations revenue edged up 2% to $601.3 million. * Announced sale of the medical business; raised 2026 adjusted EBITDA outlook to $662 million-$672 million, non-GAAP EPS to $4.70-$4.80. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BWX Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608031609BIZWIRE_USPR_____20260803_BW655700) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)